: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Gynecology

Free Subscription

Articles published in Gynecol Oncol
Retrieve available abstracts of 523 articles:
HTML format
Text format

Single Articles

February 2012

PENNINGTON KP , Swisher EM
Hereditary ovarian cancer: Beyond the usual suspects.
Gynecol Oncol. 2012;124:347-53.
PubMed Text format Related articles Abstract available

NELSON BH
Killer T cells to the rescue in ovarian cancer.
Gynecol Oncol. 2012;124:178-9.
PubMed Text format Related articles

KARLAN BY
Gynecologic oncology: update 2012.
Gynecol Oncol. 2012;124:177.
PubMed Text format Related articles

January 2012

GYLLENSTEN U , Gustavsson I, Lindell M, Wilander E, et al
Primary high-risk HPV screening for cervical cancer in post-menopausal women.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

BROTTO LA , Erskine Y, Carey M, Ehlen T, et al
A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

KATANYOO K , Sanguanrungsirikul S, Manusirivithaya S
Comparison of Treatment Outcomes between Squamous Cell Carcinoma and Adenocarcinoma in Locally Advanced Cervical Cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

ANDIKYAN V , Khoury-Collado F, Sonoda Y, Gerst SR, et al
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

SONG T , Choi CH, Cho YJ, Sung CO, et al
Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

CLIBY W , Aletti G, Chi D, Bristow R, et al
RE: Defining the limits of radical cytoreductive surgery in ovarian cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles

GALIC V , Herzog TJ, Lewin SN, Neugut AI, et al
Prognostic Significance of Adenocarcinoma Histology in Women with Cervical Cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

LIM MC , Park SY
Standardization of cytoreductive surgery is a precondition for clinical trials of ovarian cancer including cytoreductive surgery and/or neoadjuvant chemotherapy.
Gynecol Oncol. 2012.
PubMed Text format Related articles

RUBATT JM , Darcy KM, Tian C, Muggia F, et al
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

PAREJA R , Nick AM, Schmeler KM, Frumovitz M, et al
Quality of laparoscopic radical hysterectomy in developing countries: A comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

HANNA RK , Zhou C, Malloy KM, Gehrig PA, et al
Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

POURGHOLAMI MH , Mekkawy AH, Badar S, Morris DL, et al
Minocycline inhibits growth of epithelial ovarian cancer.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

GUNDERSON CC , Fader AN, Carson KA, Bristow RE, et al
Oncologic and Reproductive Outcomes with Progestin Therapy in Women with Endometrial Hyperplasia and Grade 1 Adenocarcinoma: A Systematic Review.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

WORLEY MJ JR , Anwandter C, Sun CC, Dos Reis R, et al
Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

BURBOS N , Musonda P, Crocker SG, Morris EP, et al
Outcome of investigations for postmenopausal vaginal bleeding in women under the age of 50 years.
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

MONSONEGO J , Hudgens MG, Zerat L, Zerat JC, et al
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
Gynecol Oncol. 2012.
PubMed Text format Related articles Abstract available

ANSALONI L , De Iaco P, Frigerio L
Re: "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperi
Gynecol Oncol. 2012.
PubMed Text format Related articles

THRALL MM , Gray HJ, Goff BA
Letter-to-the Editor "Trends in treatment of advanced epithelial ovarian cancer in the Medicare population"
Gynecol Oncol. 2012.
PubMed Text format Related articles

BURGER RA
Advances in ovarian cancer disease control.
Gynecol Oncol. 2012;124:5-9.
PubMed Text format Related articles

VERGOTE I , Leunen K, Amant F
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?
Gynecol Oncol. 2012;124:1-2.
PubMed Text format Related articles

MUTCH DG
The more things change the more they stay the same.
Gynecol Oncol. 2012;124:3-4.
PubMed Text format Related articles

VAN HANEGEM N , Barroilhet LM, Nucci MR, Bernstein M, et al
Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
Gynecol Oncol. 2012;124:72-7.
PubMed Text format Related articles Abstract available

FORNER DM , Lampe B
Exenteration in the treatment of Stage III/IV vulvar cancer.
Gynecol Oncol. 2012;124:87-91.
PubMed Text format Related articles Abstract available

December 2011

CARRARA L , Guzzo F, Roque DM, Bellone S, et al
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HOCKEL M , Horn LC, Einenkel J
Laterally extended parametrectomy in nodal positive early stage cervical cancer: Right direction on an improper way.
Gynecol Oncol. 2011.
PubMed Text format Related articles

CHEN C , Li W, Li F, Liu P, et al
Classical and nerve-sparing radical hysterectomy: An evaluation of the nerve trauma in cardinal ligament.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PARK JY , Jin KL, Kim DY, Kim JH, et al
Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SEEGER A , Kolbl H, Petry IB, Gebhard S, et al
p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALHILLI MM , Dowdy SC, Weaver AL, St Sauver JL, et al
Incidence and Factors Associated with Synchronous Ovarian and Endometrial Cancer: A Population-Based Case-control Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHMELER KM , Sood AK, Bell-McGuinn KM, Coleman RL, et al
Proceedings from the 9th International Conference on Ovarian Cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

KOYUNCUOGLU M , Okyay E, Saatli B, Olgan S, et al
Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DU XL , Tao J, Sheng XG, Lu CH, et al
Intensity-modulated radiation therapy for advanced cervical cancer: An comparison of dosimetric and clinical outcomes with conventional radiotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROSE PG , Sill MW, McMeekin DS, Ahmed A, et al
A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHIANG YC , Qiu JT, Chang CL, Wang PH, et al
Brain Metastases from Epithelial Ovarian Carcinoma: Evaluation of Prognosis and Managements - A Taiwanese Gynecologic Oncology Group (TGOG) Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COLE LA
Minimally-Aggressive Gestational Trophoblastic Neoplasms.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

XU JL , Commins J, Partridge E, Riley TL, et al
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MACCIO A , Madeddu C, Gramignano G, Mulas C, et al
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ANTONSEN SL , Ulrich L, Hogdall C
Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

EVANS JJ , Chitcholtan K, Dann JM, Guilford P, et al
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BARTELS PH , Garcia FA, Trimble CL, Kauderer J, et al
Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

STORMS AA , Sukumvanich P, Monaco SE, Beriwal S, et al
Mucinous Tumors of the Ovary: Diagnostic Challenges at Frozen Section and Clinical Implications.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GOULD N , Sill MW, Mannel RS, Thaker PH, et al
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic O
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BARLIN JN , Yu C, Hill EK, Zivanovic O, et al
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WHITWORTH JM , Londono-Joshi AI, Sellers JC, Oliver PJ, et al
The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

STAVRAKA C , Ford A, Ghaem-Maghami S, Crook T, et al
A study of symptoms described by ovarian cancer survivors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TEWARI KS , Filiaci VL, Spirtos NM, Mannel RS, et al
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HOCKEL M , Horn LC, Tetsch E, Einenkel J, et al
Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SUNDAR S , Wu J, Hillaby K, Yap J, et al
A systematic review evaluating the relationship between Progression free survival and Post Progression survival in advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DEL CARMEN MG , Birrer M, Schorge JO
Carcinosarcoma of the ovary: A review of the literature.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WOLFSON AH , Varia MA, Moore D, Rao GG, et al
ACR Appropriateness Criteria(R) role of adjuvant therapy in the management of early stage cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHUMMER M , Drescher C, Forrest R, Gough S, et al
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MARKMAN M
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.
Gynecol Oncol. 2011.
PubMed Text format Related articles

NUGENT EK , Bishop EA, Mathews CA, Moxley KM, et al
Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BIFULCO G , Miele C, Di Jeso B, Beguinot F, et al
Endoplasmic reticulum stress is activated in endometrial adenocarcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG X , Samadi AK, Roby KF, Cohen MS, et al
Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BAKER J , Obermair A, Gebski V, Janda M, et al
Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MACKAY HJ , Buckanovich RJ, Hirte H, Correa R, et al
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COSTA S , Venturoli S, Negri G, Sideri M, et al
Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: An analysis of 166 cases.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ARMSTRONG DK , Visvanathan K
The "luxury" of second malignancies.
Gynecol Oncol. 2011;123:453-4.
PubMed Text format Related articles

November 2011

FAIRFIELD KM , Murray KM, Wierman HR, Han PK, et al
Disparities in Hospice Care among Older Women Dying with Ovarian Cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RANDALL LM , Sill MW, Burger RA, Monk BJ, et al
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MA J , Zhu Q, Han S, Zhang Y, et al
Effect of Socio-Economic Factors on Delayed Access to Health Care among Chinese Cervical Cancer Patients with Late Rectal Complications after Radiotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ANDERSON KA , Kwekkeboom KL
A systematic review of sexual concerns reported by gynecological cancer survivors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VENKAT P , Chen LM, Young-Lin N, Kiet TK, et al
An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CIBULA D , Abu-Rustum NR, Dusek L, Zikan M, et al
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VON GRUENIGEN VE , Huang HQ, Gil KM, Frasure HE, et al
The Association Between Quality of Life Domains and Overall Survival in Ovarian Cancer Patients During Adjuvant Chemotherapy: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BIFULCO G , De Rosa N, Tornesello ML, Piccoli R, et al
Quality of life, lifestyle behavior and employment experience: A comparison between young and midlife survivors of gynecology early stage cancers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BECK TL , Singhal PK, Ehrenberg HM, Rose PG, et al
Endometrial Stromal Sarcoma: analysis of recurrence following adjuvant treatment.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GROVER S , Hill-Kayser CE, Vachani C, Hampshire MK, et al
Patient Reported Late Effects of Gynecological Cancer Treatment.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PAXTON RJ , Garcia-Prieto C, Berglund M, Hernandez M, et al
A randomized parallel-group dietary study for stage ii-iv ovarian cancer survivors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALEMANY L , Perez C, Tous S, Llombart-Bosch A, et al
Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LOUWERS JA , Berkhof J, Zaal A, Kocken M, et al
HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MENG E , Taylor B, Ray A, Shevde LA, et al
Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MONTAVON C , Gloss BS, Warton K, Barton CA, et al
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VISHNU P , Colon-Otero G, Kennedy GT, Marlow LA, et al
RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TIAN C , Ambrosone CB, Darcy KM, Krivak TC, et al
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LONG KC , Zhou Q, Hensley ML, Alektiar KM, et al
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COLOMBO N , Mangili G, Mammoliti S, Kalling M, et al
A phase II study of aflibercept in patients with advainced epithelial ovarian cancer and symptomatic malignant ascites.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TERPLAN M , Schluterman N, McNamara EJ, Tracy JK, et al
Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

JIANG J , Zhao LJ, Zhao C, Zhang G, et al
Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SAVELLI L , Testa AC, Mabrouk M, Zannoni L, et al
A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHIN SJ , Kim KR, Song DE, Ro JY, et al
Recognition of parametrial invasion, an important landmark when treating cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BOREN TP , Carrick K, Kehoe SM, Lea J, et al
Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MODESITT SC , Geffel DL, Via J, Weltman A, et al
Morbidly obese women with and without endometrial cancer: Are there differences in measured physical fitness, body composition, or hormones?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FREY MK , Ward NM, Caputo TA, Taylor J, et al
Lymphatic ascites following pelvic and paraaortic lymphadenectomy procedures for gynecologic malignancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WERNER HM , Trovik J, Marcickiewicz J, Tingulstad S, et al
Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CORREA DD , Hess LM
Cognitive Function and Quality of Life in Ovarian Cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KANG WD , Choi HS, Kim SM
Prediction of persistent gestational trophobalstic neoplasia: The role of hCG level and ratio in 2 weeks after evacuation of complete mole.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEITAO MM JR , Hensley ML, Barakat RR, Aghajanian C, et al
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KOLOMAINEN DF , Daponte A, Barton DP, Pennert K, et al
Outcomes of surgical management of bowel obstruction in relapsed Epithelial Ovarian Cancer (EOC).
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RAMIREZ PT , Adams S, Boggess JF, Burke WM, et al
Robotic-Assisted Surgery in Gynecologic Oncology: A Society of Gynecologic Oncology Consensus Statement Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
Gynecol Oncol. 2011.
PubMed Text format Related articles

PENNER KR , Dorigo O, Aoyama C, Ostrzega N, et al
Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

JONES JM , Ferguson S, Edwards E, Walton T, et al
Experiences of care delivery: Endometrial cancer survivors at end of treatment.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MOORE DH , Ali S, Koh WJ, Michael H, et al
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

EIRIKSSON L , Wells T, Steed H, Schepansky A, et al
Combined methotrexate-dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VOGL TJ , Naguib NN, Lehnert T, Nour-Eldin NE, et al
Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: Indications, outcomes and role in patient's management.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LUKOWSKI J , Gil KM, Jenison E, Hopkins M, et al
Endometrial cancer survivors' assessment of the benefits of exercise.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DIAZ-PADILLA I , Amir E, Marsh S, Liu G, et al
Genetic Polymorphisms as Predictive and Prognostic Biomarkers in Gynecological Cancers: A Systematic Review.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

EINSTEIN MH , Rash JK, Chappell RJ, Swietlik JM, et al
Quality of life in cervical cancer survivors: Patient and provider perspectives on common complications of cervical cancer and treatment.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GOFF BA , Lowe KA, Kane JC, Robertson MD, et al
Symptom Triggered Screening for Ovarian Cancer: A Pilot Study of Feasibility and Acceptability.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MAHMUD SM , Sangwa-Lugoma G, Nasr SH, Kayembe PK, et al
COMPARISON of Human Papillomavirus Testing and Cytology for Cervical Cancer Screening in a Primary Health Care Setting in the Democratic Republic of Congo.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NAGEL CI , Backes FJ, Hade EM, Cohn DE, et al
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DALTON HJ , Yu X, Hu L, Kapp DS, et al
An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

EINSTEIN MH , Klobocista M, Hou JY, Lee S, et al
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WAHNER HENDRICKSON AE , Oberg AL, Glaser G, Camoriano JK, et al
A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PRADHAN TS , Stevens EE, Ablavsky M, Salame G, et al
FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?
Gynecol Oncol. 2011;123:221-4.
PubMed Text format Related articles Abstract available

HENRETTA MS , Anderson CL, Angle JF, Duska LR, et al
It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.
Gynecol Oncol. 2011;123:342-5.
PubMed Text format Related articles Abstract available

CHAUDARY N , Milosevic M, Hill RP
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Gynecol Oncol. 2011;123:393-400.
PubMed Text format Related articles Abstract available

GOUY S , Kane A, Uzan C, Gauthier T, et al
Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy: about fourteen consecutive cases.
Gynecol Oncol. 2011;123:329-32.
PubMed Text format Related articles Abstract available

CHAGAS BS , Batista MV, Guimaraes V, Balbino VQ, et al
New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil.
Gynecol Oncol. 2011;123:284-8.
PubMed Text format Related articles Abstract available

REGAUER S
Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women.
Gynecol Oncol. 2011;123:289-94.
PubMed Text format Related articles Abstract available

NICOL AF , Monsonego J
Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers.
Gynecol Oncol. 2011;123:179-81.
PubMed Text format Related articles

October 2011

SEMAAN A , Ali-Fehmi R, Munkarah AR, Bandyopadhyay S, et al
Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: A population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PAPADAKOS J , Bussiere-Cote S, Abdelmutti N, Catton P, et al
Informational needs of gynecologic cancer survivors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SEHOULI J , Alvarez AM, Manouchehrpour S, Ghatage P, et al
A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RODRIGUEZ AO , Llacuachaqui M, Pardo GG, Royer R, et al
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ANDERSEN MR , Sweet E, Lowe KA, Standish LJ, et al
Involvement in decision-making about treatment and ovarian cancer survivor quality of life.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LINDER N , Butzow R, Lassus H, Lundin M, et al
Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MITSUI H , Shibata K, Suzuki S, Umezu T, et al
Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HWANG WT , Adams SF, Tahirovic E, Hagemann IS, et al
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HORN LC , Kellner C, Scherling R, Hockel M, et al
Ultrastaging for micrometastases in para-aortic lymph nodes in patients with carcinoma of the uterine cervix.
Gynecol Oncol. 2011.
PubMed Text format Related articles

ELSAHWI KS , Hooper C, De Leon MC, Gallo TN, et al
Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KALOGERA E , Scholler N, Powless C, Weaver A, et al
Correlation of Serum HE4 with Tumor Size and Myometrial Invasion in Endometrial Cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FANNING J , Hossler CA, Kesterson JP, Donahue RN, et al
Expression of the Opioid Growth Factor- Opioid Growth Factor Receptor Axis in Human Ovarian Cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GARCIA AA , Sill MW, Lankes HA, Godwin AK, et al
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FERRANDINA G , Mantegna G, Petrillo M, Fuoco G, et al
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NICK AM , Frumovitz MM, Soliman PT, Schmeler KM, et al
Fertility sparing surgery for treatment of early-stage cervical cancer: Open vs. robotic radical trachelectomy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CIBULA D , Querleu D, Morrow CP
Terminology and classification system of radical hysterectomy.
Gynecol Oncol. 2011.
PubMed Text format Related articles

EINSTEIN MH , Frimer M, Kuo DY, Reimers LL, et al
Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MEISER B , Gleeson M, Kasparian N, Barlow-Stewart K, et al
There is no decision to make: Experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHON HS , Marchion DC, Xiong Y, Chen N, et al
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RUNGRUANG B , Miller A, Richard SD, Hamilton CA, et al
Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MUNKSGAARD PS , Blaakaer J
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GUNTUPALLI SR , Zighelboim I, Kizer NT, Zhang Q, et al
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GARDNER GJ , Baser RE, Brady MF, Bristow RE, et al
CA125 Regression in Ovarian Cancer Patients Treated with Intravenous versus Intraperitoneal Platinum-Based Chemotherapy: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FRANCIS JH , Kleinerman RA, Seddon JM, Abramson DH, et al
Increased Risk of Secondary Uterine Leiomyosarcoma in Hereditary Retinoblastoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

O'MALLEY DM
Response to letter to the editor in response to "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer"
Gynecol Oncol. 2011.
PubMed Text format Related articles

LI Y , Wang W, Wang W, Yang R, et al
Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MANCHANDA R , Drapkin R, Jacobs I, Menon U, et al
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SUN HD , Lin H, Jao MS, Wang KL, et al
A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MHAWECH-FAUCEGLIA P , Wang D, Syriac S, Godoy H, et al
Synuclein-gamma (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEE YY , Choi CH, Sung CO, Do IG, et al
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SMRKOLJ S , Pogacnik RK, Slabe N, Rakar S, et al
Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZANNONI GF , Scambia G, Gallo D
The dualistic model of endometrial cancer: The challenge of classifying grade 3 endometrioid carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles

EL-SAHWI KS , Illuzzi J, Varughese J, Carusillo N, et al
A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KHOURY-COLLADO F , Einstein MH, Bochner BH, Alektiar KM, et al
Pelvic exenteration with curative intent for recurrent uterine malignancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PARK YA , Lee JW, Choi JJ, Jeon HK, et al
The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PODZIELINSKI I , Randall ME, Breheny PJ, Escobar PF, et al
Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SONG S , Song C, Kim HJ, Wu HG, et al
20year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALTUNTAS CZ , Jaini R, Kesaraju P, Jane-Wit D, et al
Autoimmune mediated regulation of ovarian tumor growth.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NAKAMURA K , Imafuku N, Nishida T, Niwa I, et al
Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

YANG C , Cai J, Wang Q, Tang H, et al
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG X , Dai B, Zhang B, Wang Z, et al
Vitamin A and risk of cervical cancer: A meta-analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

IOFFE YJ , Chiappinelli KB, Mutch DG, Zighelboim I, et al
Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ELATTAR A , Warburton KG, Mukhopadhyay A, Freer RM, et al
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LIFFORD KJ , Fraser L, Rosenthal AN, Rogers MT, et al
Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS).
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROMERO IL , Lee W, Mitra AK, Gordon IO, et al
The effects of 17beta-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MONK BJ , Blessing JA, Street DG, Muller CY, et al
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROSSI EC , Ivanova A, Boggess JF
Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HAZEWINKEL MH , Gietelink L, van der Velden J, Burger MP, et al
Renal ultrasound to detect hydronephrosis: A need for routine imaging after radical hysterectomy?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KLEPPE M , Wang T, Van Gorp T, Slangen BF, et al
Lymph node metastasis in stages I and II ovarian cancer: A review.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TANNER EJ , Black DR, Zivanovic O, Kehoe SM, et al
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BRISTOW RE
"Kegel ball" induced vaginal cuff dehiscence following radical abdominal hysterectomy: Laparoscopically-assisted transvaginal retrieval.
Gynecol Oncol. 2011.
PubMed Text format Related articles

BRUNNER A , Hinterholzer S, Riss P, Heinze G, et al
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GORDON AN , Teneriello M, Janicek MF, Hines J, et al
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BACKES FJ , Mitchell E, Hampel H, Cohn DE, et al
Endometrial cancer patients and compliance with genetic counseling: Room for improvement.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARTINO MA , Shubella J, Thomas MB, Morcrette RM, et al
A cost analysis of postoperative management in endometrial cancer patients treated by robotics versus laparoscopic approach.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ELSAHWI KS , Barber E, Illuzzi J, Buza N, et al
The significance of perineural invasion in early-stage cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BARLIN JN , Levine DA
The evolving pathogenesis model of high-grade pelvic serous carcinoma.
Gynecol Oncol. 2011;123:1-2.
PubMed Text format Related articles

HELPMAN L , Grisaru D, Covens A
Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe?
Gynecol Oncol. 2011;123:95-8.
PubMed Text format Related articles Abstract available

PALOMBA S , Oppedisano R, Annunziata G, Zullo F, et al
Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: a case report.
Gynecol Oncol. 2011;123:172-3.
PubMed Text format Related articles

VAN DER MEIDE WF , Snellenberg S, Meijer CJ, Baalbergen A, et al
Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
Gynecol Oncol. 2011;123:116-22.
PubMed Text format Related articles Abstract available

KARST AM , Levanon K, Duraisamy S, Liu JF, et al
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.
Gynecol Oncol. 2011;123:5-12.
PubMed Text format Related articles Abstract available

September 2011

SEAMON LG , Tarrant RL, Fleming ST, Vanderpool RC, et al
Cervical cancer survival for patients referred to a tertiary care center in Kentucky.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VISWANATHAN AN , Macklin EA, Berkowitz R, Matulonis U, et al
The importance of chemotherapy and radiation in uterine papillary serous carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WRIGHT JD , Lewin SN, Deutsch I, Burke WM, et al
Defining the limits of radical cytoreductive surgery for ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HIGASHI M , Kajiyama H, Shibata K, Mizuno M, et al
Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KATANYOO K , Tangjitgamol S, Chongthanakorn M, Tantivatana T, et al
Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BONDURANT AE , Huang Z, Whitaker RS, Simel LR, et al
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEUNG F , Terzibachian JJ
Re: "The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma"
Gynecol Oncol. 2011.
PubMed Text format Related articles

RAMASUBBAIAH R , Perkins SM, Schilder J, Whalen C, et al
Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

POKRZYWINSKI R , Secord AA, Havrilesky LJ, Puls LE, et al
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: Results from a randomized clinical trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

THRALL MM , Gray HJ, Symons RG, Weiss NS, et al
Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

YANG YI , Kim JH, Lee KT, Choi JH, et al
Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HOCKEL M , Horn LC
Three-dimensional classification of radical hysterectomy: New saddle for an old horse.
Gynecol Oncol. 2011.
PubMed Text format Related articles

TOMITA N , Toita T, Kodaira T, Shinoda A, et al
Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KANG S , Yoo HJ, Hwang JH, Lim MC, et al
Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ADAMS SF , Marsh EB, Elmasri W, Halberstadt S, et al
A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TANNER EJ , Leitao MM Jr, Garg K, Chi DS, et al
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROWLANDS IJ , Nagle CM, Spurdle AB, Webb PM, et al
Gynecological conditions and the risk of endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HAMILTON CA , Krivak TC, Maxwell GL
Re: Implications of upper abdominal disease in advanced ovarian cancer after surgical cytoreduction and relation with tumor biology.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SHIH KK , Garg K, Soslow RA, Chi DS, et al
Accuracy of frozen section diagnosis of ovarian borderline tumor.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LASECKA L , Dixon PH, Molokhia M, Sharma N, et al
667C>T and 1298A>C polymorphisms of MTHFR do not predict response to methotrexate in patients with gestational trophoblastic neoplasia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CARSER JE , Quinn JE, Michie CO, O'Brien EJ, et al
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SANFILIPPO R , Grosso F, Jones RL, Banerjee S, et al
Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHI DS , Musa F, Dao F, Zivanovic O, et al
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PARK JY , Kim DY, Kim JH, Kim YM, et al
Micropapillary pattern in serous borderline ovarian tumors: Does it matter?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MAZUMDER INDRA D , Singh RK, Mitra S, Dutta S, et al
Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MANEO A , Sideri M, Scambia G, Boveri S, et al
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NGO C , Alran S, Plancher C, Fourchotte V, et al
Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: A ten-year follow up of 257 patients treated at a single institution.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALVAREZ SECORD A , Darcy KM, Hutson A, Huang Z, et al
The regulation of MASPIN expression in epithelial ovarian cancer: Association with p53 status, and MASPIN promoter methylation: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHO JA , Park H, Lim EH, Kim KH, et al
Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KOSKAS M , Bendifallah S, Luton D, Darai E, et al
Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NAUMANN RW
The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BATS AS , Buenerd A, Querleu D, Leblanc E, et al
Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: A prospective, multicenter study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COHN DE
What does cost have to do with it?
Gynecol Oncol. 2011;122:465-6.
PubMed Text format Related articles

ALONSO I , Fuste V, del Pino M, Castillo P, et al
Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?
Gynecol Oncol. 2011;122:509-14.
PubMed Text format Related articles Abstract available

GERSHON R , Aviel-Ronen S, Korach J, Daniel-Carmi V, et al
FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.
Gynecol Oncol. 2011;122:580-4.
PubMed Text format Related articles Abstract available

MOXLEY KM , Fader AN, Rose PG, Case AS, et al
Malignant melanoma of the vulva: an extension of cutaneous melanoma?
Gynecol Oncol. 2011;122:612-7.
PubMed Text format Related articles Abstract available

August 2011

COTICCHIA CM , Curatolo AS, Zurakowski D, Yang J, et al
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MANNEL RS
Anti-angiogenic therapy in ovarian cancer; what is the best population?
Gynecol Oncol. 2011.
PubMed Text format Related articles

SOLIMAN PT , Frumovitz M, Sun CC, Dos Reis R, et al
Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PHIPPEN NT , Lowery WJ, Barnett JC, Hall LA, et al
Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: A pilot study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VOSS MA , Ganesan R, Ludeman L, McCarthy K, et al
Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-A clinical and pathological evaluation.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

JUDSON PL , Dickson EL, Argenta PA, Xiong Y, et al
A prospective, randomized trial of integrative medicine for women with ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FERRERO A , Dompe D, Ravarino N, Ramella A, et al
Angiogenesis and molecular markers in advanced epithelial ovarian cancer: A retrospective study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SIGNORELLI M , Guerra L, Montanelli L, Crivellaro C, et al
Preoperative staging of cervical cancer: Is 18-FDG-PET/CT really effective in patients with early stage disease?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VAY A , Kumar S, Seward S, Semaan A, et al
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

AKHTAR-DANESH N , Elit L, Lytwyn A
Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: A population-based study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HYMAN DM , Zhou Q, Arnold AG, Grisham RN, et al
Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ONUJIOGU N , Johnson T, Seo S, Mijal K, et al
Survivors of endometrial cancer: Who is at risk for sexual dysfunction?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SANDADI S , Frasure HE, Broderick MJ, Waggoner SE, et al
The effect of sleep disturbance on quality of life in women with ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HOGDALL C , Fung ET, Christensen IJ, Nedergaard L, et al
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KICHENADASSE G , Sukumaran S, Karapetis C
Early stage ovarian cancers: Angiogenesis inhibition and clear cell cancers.
Gynecol Oncol. 2011.
PubMed Text format Related articles

CHUA TC
Implications of upper abdominal disease in advanced ovarian cancer after surgical cytoreduction and relation with tumor biology.
Gynecol Oncol. 2011.
PubMed Text format Related articles

TROPE A , Jonassen CM, Sjoborg KD, Nygard M, et al
Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

OVESTAD IT , Vennestrom U, Andersen L, Gudlaugsson E, et al
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG Z , Knobloch TJ, Seamon LG, Stoner GD, et al
A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHIAVONE MB , Smok D, Wright TC, Wright JD, et al
High-grade uterine sarcoma during pregnancy.
Gynecol Oncol. 2011.
PubMed Text format Related articles

GARG G , Morris RT, Solomon L, Toy EP, et al
Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MABUCHI S , Okazawa M, Isohashi F, Matsuo K, et al
Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PLANTE M , Smith EB, Cox S, Silverberg K, et al
The case of a viable pregnancy post vaginal radical trachelectomy followed by combined chemo-radiation therapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SALANI R , Nagel CI, Drennen E, Bristow RE, et al
Recurrence patterns and surveillance for patients with early stage endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DIZON DS , Sill MW, Gould N, Rubin SC, et al
Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TEWARI KS , Monk BJ
American society of clinical oncology 2011 annual meeting update: summary of selected gynecologic cancer abstracts.
Gynecol Oncol. 2011;122:209-12.
PubMed Text format Related articles

SINGH M , Darcy KM, Brady WE, Clubwala R, et al
Cadherins, catenins and cell cycle regulators: Impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

UNGAR L , Palfalvi L, Tarnai L, Horanyi D, et al
Surgical treatment of lymph node metastases in stage IB cervical cancer. The laterally extended parametrectomy (LEP) procedure: Experience with a 5year follow-up.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

EDWARDS RP
Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: time for a prospective trial?
Gynecol Oncol. 2011;122:207-8.
PubMed Text format Related articles

LINDSTROM AK , Asplund A, Hellberg D
Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.
Gynecol Oncol. 2011;122:372-6.
PubMed Text format Related articles Abstract available

HOCKEL M , Horn LC, Illig R, Dornhofer N, et al
Ontogenetic anatomy of the distal vagina: relevance for local tumor spread and implications for cancer surgery.
Gynecol Oncol. 2011;122:313-8.
PubMed Text format Related articles Abstract available

KOCKEN M , Baalbergen A, Snijders PJ, Bulten J, et al
High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.
Gynecol Oncol. 2011;122:297-302.
PubMed Text format Related articles Abstract available

SZNURKOWSKI JJ , Zawrocki A, Emerich J, Sznurkowska K, et al
Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests.
Gynecol Oncol. 2011;122:307-12.
PubMed Text format Related articles Abstract available

KIM JH , Bae SN, Lee CW, Song MJ, et al
A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR(R)).
Gynecol Oncol. 2011;122:303-6.
PubMed Text format Related articles Abstract available

ZHAO C , Chen X, Onisko A, Kanbour A, et al
Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.
Gynecol Oncol. 2011;122:291-6.
PubMed Text format Related articles Abstract available

CHAPMAN JS , Powell CB, McLennan J, Crawford B, et al
Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.
Gynecol Oncol. 2011;122:339-43.
PubMed Text format Related articles Abstract available

ROY M , Bouchard-Fortier G, Popa I, Gregoire J, et al
Value of sentinel node mapping in cancer of the cervix.
Gynecol Oncol. 2011;122:269-74.
PubMed Text format Related articles Abstract available

July 2011

BAGGOTT CD , Einstein MH, Miranpuri A, Rose SL, et al
What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases?
Gynecol Oncol. 2011.
PubMed Text format Related articles

HO KC , Wang CC, Qiu JT, Lai CH, et al
Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CAPRI S , Gasparini R, Panatto D, Demarteau N, et al
Letter to the Editor of Gynecologic Oncology.
Gynecol Oncol. 2011.
PubMed Text format Related articles

BRARD L , Lange TS, Robison K, Kim KK, et al
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BODMER M , Becker C, Meier C, Jick SS, et al
Use of metformin and the risk of ovarian cancer: A case-control analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHI M , Zhang H, Li M, Xue J, et al
Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LANGSTRAAT C , Aletti GD, Cliby WA
Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: A delicate balance requiring individualization.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARKMAN M
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

ZOU H , Wang D, Gan X, Jiang L, et al
Low TWEAK expression is correlated to the progression of squamous cervical carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

YEO RM , Chia YN, Namuduri RP, Yap SP, et al
Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DUTTA S , Wang FQ, Wu HS, Mukherjee TJ, et al
The NF-kappaB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RAMONDETTA LM , Urbauer D, Brown AJ, Richardson G, et al
Work related stress among gynecologic oncologists.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GAYAR OH , Robbins JR, Parikh K, Lu M, et al
Hysterectomy for uterine adenocarcinoma in the elderly: Tumor characteristics, and long-term outcome.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BIGE O , Demir A, Saygili U, Gode F, et al
Frozen section diagnoses of 578 ovarian tumors made by pathologists with and without expertise on gynecologic pathology.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VICUS D , Beiner ME, Clarke B, Klachook S, et al
Ovarian immature teratoma: Treatment and outcome in a single institutional cohort.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEVY A , Caramella C, Chargari C, Medjhoul A, et al
Accuracy of Diffusion-Weighted Echo-Planar MR Imaging and ADC Mapping in the evaluation of residual Cervical Carcinoma after radiation therapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NAKAMURA K , Hongo A, Kodama J, Hiramatsu Y, et al
The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BAMIAS A , Karadimou A, Soupos N, Sotiropoulou M, et al
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROSE PG , Ali S
Commentary on "Is there a real standard for stage IVa cervical cancer?"
Gynecol Oncol. 2011.
PubMed Text format Related articles

BEHBAKHT K , Sill MW, Darcy KM, Rubin SC, et al
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TEOH D , Berchuck A, Secord AA, Lee PS, et al
Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CONVERY PA , Cantrell LA, Di Santo N, Broadwater G, et al
Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SUBRAMANIAM A , Kim KH, Bryant SA, Kimball KJ, et al
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHIH KK , Garg K, Levine DA, Kauff ND, et al
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MUNKSGAARD PS , Blaakaer J
The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BAKKUM-GAMEZ JN , Mariani A, Dowdy SC, Weaver AL, et al
The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

REIN DT , Volkmer A, Beyer IM, Curiel DT, et al
Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

YING X , Li-Zhi L, Li-Ping C, Min Z, et al
Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GIATROMANOLAKI A , Koukourakis MI, Koutsopoulos A, Chloropoulou P, et al
High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FANNING J , Yacoub E, Hojat R
Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: Success, morbidity and survival.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

OLIVER KE , Enewold LR, Zhu K, Conrads TP, et al
Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZAND B , Ramirez PT
Re: "Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer"
Gynecol Oncol. 2011.
PubMed Text format Related articles

BAUMANN K , Pfisterer J, Wimberger P, Burchardi N, et al
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KING ER , Zu Z, Tsang YT, Deavers MT, et al
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GARDNER GJ , Reidy-Lagunes D, Gehrig PA
Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document.
Gynecol Oncol. 2011;122:190-8.
PubMed Text format Related articles Abstract available

SYMONDS RP , Davidson SE, Chan S, Reed NS, et al
SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

Retraction to "A3' UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer" [Gynecol. Oncol. 120 (2011) S3].
Gynecol Oncol. 2011;122:205.
PubMed Text format Related articles

KIM KK , Kawar NM, Singh RK, Lange TS, et al
Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.
Gynecol Oncol. 2011;122:183-9.
PubMed Text format Related articles Abstract available

JONES IS , Crandon A, Sanday K
Paget's disease of the vulva: Diagnosis and follow-up key to management; a retrospective study of 50 cases from Queensland.
Gynecol Oncol. 2011;122:42-4.
PubMed Text format Related articles Abstract available

MAHDI H , Kumar S, Hanna RK, Munkarah AR, et al
Disparities in treatment and survival between African American and White women with vaginal cancer.
Gynecol Oncol. 2011;122:38-41.
PubMed Text format Related articles Abstract available

BAANDRUP L , Varbo A, Munk C, Johansen C, et al
In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study.
Gynecol Oncol. 2011;122:45-9.
PubMed Text format Related articles Abstract available

KRUSE AJ , van Gorp T, Van de Vijver KK
Re: Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix.
Gynecol Oncol. 2011;122:202-3.
PubMed Text format Related articles

June 2011

BODNAR L , Gornas M, Szczylik C
Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ORR JM , Barnett JC, Leath CA 3rd
Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MA X , Zhang J, Liu S, Huang Y, et al
Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HENRIQUEZ-HERNANDEZ LA , Lloret M, Pinar B, Bordon E, et al
BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CLARKE CH , Yip C, Badgwell D, Fung ET, et al
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LU D , Kuhn E, Bristow RE, Giuntoli RL 2nd, et al
Comparison of candidate serologic markers for type I and type II ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KODAMA J , Kusumoto T, Nakamura K, Seki N, et al
Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

AKBAYIR O , Corbacioglu A, Numanoglu C, Guleroglu FY, et al
Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma by transvaginal ultrasound.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALAZZAM M , Young T, Coleman R, Hancock B, et al
Predicting gestational trophoblastic neoplasia (GTN): Is urine hCG the answer?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FURUYA M , Yoneyama T, Miyagi E, Tanaka R, et al
Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SANTIN AD , Sill MW, McMeekin DS, Leitao MM Jr, et al
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HAMILTON CA , Miller A, Miller C, Krivak TC, et al
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BELLATI F , Gasparri ML, Benedetti Panici P
Is There a Real Standard For Stage IVa Cervical Cancer?
Gynecol Oncol. 2011.
PubMed Text format Related articles

HOSKINS E , Rodriguez-Canales J, Hewitt SM, Elmasri W, et al
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LESNOCK JL , Farris C, Krivak TC, Smith KJ, et al
Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DE STEFANO I , Zannoni GF, Prisco MG, Fagotti A, et al
Cytoplasmic expression of estrogen receptor beta (ERbeta) predicts poor clinical outcome in advanced serous ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DERACO M , Kusamura S, Virzi S, Puccio F, et al
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COLOMBO PE , Boustta M, Poujol S, Jarlier M, et al
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: Experimental study in a murine model of ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SILL MW , Monk BJ
Comments on: "Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens" (Monk BJ, Sill MW, Hanjani P, Edwards R, Rotmensch J, De Geest K, et al. Gynecol Oncol. 2011 Mar
Gynecol Oncol. 2011.
PubMed Text format Related articles

CHOI JJ , Buttrick S, Zakashansky K, Nezhat F, et al
Laparoscopic adrenalectomy for isolated adrenal metastasis from cervical squamous cell carcinoma and endometrial adenocarcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles

POVEDA A , Kaye SB, McCormack R, Wang S, et al
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LANDRUM LM , Hyde J Jr, Mannel RS, McMeekin DS, et al
Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VAZQUEZ-ULLOA E , Lizano M, Aviles-Salas A, Alfaro-Moreno E, et al
Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VALARI O , Koliopoulos G, Karakitsos P, Valasoulis G, et al
Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: Predictors and clinical implications.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHIH KK , Yun E, Gardner GJ, Barakat RR, et al
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

POLTERAUER S , Hofstetter G, Grimm C, Rahhal J, et al
Relevance of gamma-glutamyltransferase - a marker for apoptotic balance - in predicting tumor stage and prognosis in cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHAH PH , Kudrimoti M, Feddock J, Randall M, et al
Adjuvant treatment for stage IIIC endometrial cancer: Options and controversies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HENRETTA MS , Scalici JM, Engelhard CL, Duska LR, et al
The revolving door: Hospital readmissions of gynecologic oncology patients.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG H , Zhao X, Yan L, Li M, et al
Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SUBRAMANIAM A , Kim KH, Bryant SA, Zhang B, et al
A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FAUCI JM , Whitworth JM, Schneider KE, Subramaniam A, et al
Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ITAMOCHI H , Yoshida T, Walker CL, Bartholomeusz C, et al
Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DOWNS L
Advances in cervical cancer treatment.
Gynecol Oncol. 2011;121:431-3.
PubMed Text format Related articles

BAST RC JR , Spriggs DR
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis.
Gynecol Oncol. 2011;121:429-30.
PubMed Text format Related articles

LEE YY , Kim TJ, Kim MJ, Kim HJ, et al
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NASSAR OA
Primary repair of rectovaginal fistulas complicating pelvic surgery by gracilis myocutaneous flap.
Gynecol Oncol. 2011;121:610-4.
PubMed Text format Related articles Abstract available

MIAO J , Fleury AC, Kushnir CL, Silver DF, et al
Post fellowship training in "new-to-them" surgical techniques: assessment of learning curve characteristics.
Gynecol Oncol. 2011;121:620-4.
PubMed Text format Related articles Abstract available

LEBLANC E , Narducci F, Farre I, Peyrat JP, et al
Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development.
Gynecol Oncol. 2011;121:472-6.
PubMed Text format Related articles Abstract available

GHEBRE RG , Posthuma R, Vogel RI, Geller MA, et al
Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer.
Gynecol Oncol. 2011;121:595-9.
PubMed Text format Related articles Abstract available

GRIMM C , Watrowski R, Baumuhlner K, Natter C, et al
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.
Gynecol Oncol. 2011;121:537-41.
PubMed Text format Related articles Abstract available

KUPETS R , Paszat L
How are women with high grade Pap smear abnormalities managed? A population based study.
Gynecol Oncol. 2011;121:499-504.
PubMed Text format Related articles Abstract available

RABBAN JT , Mackey A, Powell CB, Crawford B, et al
Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation.
Gynecol Oncol. 2011;121:466-71.
PubMed Text format Related articles Abstract available

LI J , Li Z, Wang H, Zang R, et al
Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients.
Gynecol Oncol. 2011;121:565-70.
PubMed Text format Related articles Abstract available

WATANABE T , Matsuda K, Ishihara S
Heterogeneous distribution of LOH (loss of heterozygosity) and tumor progression.
Gynecol Oncol. 2011;121:640.
PubMed Text format Related articles

May 2011

POWLESS CA , Aletti GD, Bakkum-Gamez JN, Cliby WA, et al
Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical staging.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARCHIOLE P , Tigaud JD, Costantini S, Mammoliti S, et al
Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1).
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BRISTOW RE , Ueda S, Gerardi MA, Ajiboye OB, et al
Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a Tertiary Gynecologic Oncology Referral Center.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PAN XY , Lin H, Wang YN, Zhao YW, et al
Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in gynecologic malignancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARTIGNETTI JA , Dottino PR
Response to the Letter to the Editor by Bol and van Diest regarding the review article "BRCA1 methylation and BRCA1 mutations in ovarian cancer"
Gynecol Oncol. 2011.
PubMed Text format Related articles

DEL PINO M , Rodriguez-Carunchio L, Alonso I, Torne A, et al
Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PELLICCIOTTA I , Yang CP, Goldberg GL, Shahabi S, et al
Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEREAU E , Ballester M, Darai E
Re: <<Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer>>
Gynecol Oncol. 2011.
PubMed Text format Related articles

JIANG Z , Fletcher NM, Ali-Fehmi R, Diamond MP, et al
Modulation of redox signaling promotes apoptosis in epithelial ovarian cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARKMAN M
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: A phase II study of the Gynecologic Oncology Group.
Gynecol Oncol. 2011.
PubMed Text format Related articles

LEVINSON KL , Bristow RE, Donohue PK, Kanarek NF, et al
Impact of payer status on treatment of cervical cancer at a tertiary referral center.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DRENZEK JG , Seiler NL, Jaskula-Sztul R, Rausch MM, et al
Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEE CW , Chuang LS, Kimura S, Lai SK, et al
RUNX3 functions as an oncogene in ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DINGES MM , Jaggessarsingh D, Petersen TH, Behbakht K, et al
Lobular endocervical glandular hyperplasia with extensive mucinous differentiation of endometrium and endometrial mucinous adenocarcinoma in situ: A case report and review of literature.
Gynecol Oncol. 2011.
PubMed Text format Related articles

KUDOH K , Takano M, Kouta H, Kikuchi R, et al
Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TAO T , Yang JX, Cao DY, Liu JT, et al
Management of recurrent endodermal sinus tumor of the ovary associated with pregnancy.
Gynecol Oncol. 2011.
PubMed Text format Related articles

VON GRUENIGEN VE , Frasure HE, Kavanagh MB, Lerner E, et al
Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GUERRA F , Kurelac I, Magini P, Cormio A, et al
Mitochondrial DNA genotyping reveals synchronous nature of simultaneously detected endometrial and ovarian cancers.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CIBULA D , Abu-Rustum NR, Benedetti-Panici P, Kohler C, et al
New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KAJIYAMA H , Shibata K, Mizuno M, Nawa A, et al
Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LIU J , Wang X, Zhou G, Wang H, et al
Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

JOLY F , Ray-Coquard I, Fabbro M, Donoghoe M, et al
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LU L , Schwartz P, Scarampi L, Rutherford T, et al
MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CORMIER B , Diaz JP, Shih K, Sampson RM, et al
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DAIKOKU T , Jackson L, Besnard V, Whitsett J, et al
Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEE YY , Choi CH, Do IG, Song SY, et al
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PRIEBE A , Tan L, Wahl H, Kueck A, et al
Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CRESS RD , Leiserowitz GS
Re: Surgical staging of early stage epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

KHOURY-COLLADO F , Murray MP, Hensley ML, Sonoda Y, et al
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARKMAN M
Can weekly topotecan substitute for a multi-day regimen in the treatment of ovarian cancer? Sadly, 10 years later the answer remains unknown.
Gynecol Oncol. 2011.
PubMed Text format Related articles

PARK JY , Park SK, Kim DY, Kim JH, et al
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MAHDI H , Swensen RE, Munkarah AR, Chiang S, et al
Suicide in women with gynecologic cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MANCI N , Marchetti C, Di Tucci C, Giorgini M, et al
A prospective phase II study of topotecan (Hycamtin(R)) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HERZOG TJ , Vermorken JB, Pujade-Lauraine E, Provencher DM, et al
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FAGOTTI A , Costantini B, Vizzielli G, Perelli F, et al
HIPEC in recurrent ovarian cancer patients: Morbidity-related treatment and long-term analysis of clinical outcome.
Gynecol Oncol. 2011.
PubMed Text format Related articles

JUKO-PECIREP I , Ivansson EL, Gyllensten UB
Evaluation of Fanconi anaemia genes FANCA, FANCC and FANCL in cervical cancer susceptibility.
Gynecol Oncol. 2011.
PubMed Text format Related articles

CLIBY B
CA125 surveillance and outcomes at secondary surgery: more here than meets the eye.
Gynecol Oncol. 2011;121:245-6.
PubMed Text format Related articles

LANOWSKA M , Morawietz L, Sikora A, Raber G, et al
Prevalence of lymph nodes in the parametrium of radical vaginal trachelectomy (RVT) specimen.
Gynecol Oncol. 2011;121:298-302.
PubMed Text format Related articles Abstract available

SZNURKOWSKI JJ
Letter to the Editor referring to the manuscript entitled: "New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis" recently reported by van der Steen S. et al., (Gynecol Oncol 2010;119:520-5. Epub 2010 Sep 28).
Gynecol Oncol. 2011;121:424-5.
PubMed Text format Related articles

April 2011

GERSHENSON DM
The future of gynecologic oncology: Are we headed for super-specialization?
Gynecol Oncol. 2011.
PubMed Text format Related articles

LEE M , Kim SW, Nam EJ, Yim GW, et al
The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

DONAHUE RN , McLaughlin PJ, Zagon IS
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice.
Gynecol Oncol. 2011.
PubMed Text format Related articles

HUNTSMAN DG , Gilks CB
Surgical staging of early stage epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

JAAKKOLA S , Lyytinen HK, Pukkala E, Ylikorkala O, et al
Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas.
Gynecol Oncol. 2011.
PubMed Text format Related articles

YUE C , Wang M, Ding B, Wang W, et al
Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population.
Gynecol Oncol. 2011.
PubMed Text format Related articles

WU Q , Guo R, Lin M, Zhou B, et al
MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MANNEL RS , Brady MF, Kohn EC, Hanjani P, et al
A randomized phase III trial of IV carboplatin and paclitaxel x 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles

CHEN CC , Lin JC, Jan JS, Ho SC, et al
Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

WEROHA SJ , Oberg AL, Ziegler KL, Dakhilm SR, et al
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SEGER HM , Soisson AP, Dodson MK, Rowe KG, et al
Familial clustering of endometrial cancer in a well-defined population.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MABUCHI S , Matsumoto Y, Isohashi F, Yoshioka Y, et al
Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SINGH M , Kindelberger D, Nagymanyoki Z, Ng SW, et al
Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MAY T , Rabinowe SN, Berkowitz RS, Goldstein DP, et al
Cerebral venous sinus thrombosis presenting as cerebral metastasis in a patient with choriocarcinoma following a non-molar gestation.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MYLONAS I , Matsingou C, Kaufl SD, Bruning A, et al
Inhibin/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: From immunohistochemistry to clinical testing?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TODO Y , Kato H, Okamoto K, Minobe S, et al
Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in intermediate- and high-risk endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHULTZ KA , Pacheco MC, Yang J, Williams GM, et al
Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: A report from the International Pleuropulmonary Blastoma Registry.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LIU Y , Liu H, Bai X, Ye Z, et al
Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

COLEMAN RL , Brady WE, McMeekin DS, Rose PG, et al
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BASHA R , Ingersoll SB, Sankpal UT, Ahmad S, et al
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

THRALL MM , Gray HJ, Symons RG, Weiss NS, et al
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KRIVAK TC , Darcy KM, Tian C, Bookman M, et al
Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; A Gynecologic Oncology Group Study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SONG T , Choi CH, Kim HJ, Kim MK, et al
Accuracy of frozen section diagnosis of borderline ovarian tumors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SONG T , Lee JW, Kim HJ, Kim MK, et al
Prognostic significance of DNA ploidy in stage I endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

THRALL MM , Paley P, Pizer E, Garcia R, et al
Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WRENN DC , Saigal K, Lucci JA 3rd, Pearson MJ, et al
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEITAO MM JR
Invited Letter to Editor RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancer"
Gynecol Oncol. 2011.
PubMed Text format Related articles

IBEANU O , Modesitt SC, Ducie J, von Gruenigen V, et al
Hormone replacement therapy in gynecologic cancer survivors: Why not?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MERY E , Jouve E, Guillermet S, Bourgognon M, et al
Intraoperative fluorescence imaging of peritoneal dissemination of ovarian carcinomas. A preclinical study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FEDEWA SA , Lerro C, Chase D, Ward EM, et al
Insurance status and racial differences in uterine cancer survival: A study of patients in the National Cancer Database.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

AL-BARRAK J , Santos JL, Tinker A, Hoskins P, et al
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SUN C , Reimers LL, Burk RD
Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
Gynecol Oncol. 2011;121:59-63.
PubMed Text format Related articles Abstract available

TERLOU A , van Seters M, Ewing PC, Aaronson NK, et al
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Gynecol Oncol. 2011;121:157-62.
PubMed Text format Related articles Abstract available

VALASOULIS G , Koliopoulos G, Founta C, Kyrgiou M, et al
Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia.
Gynecol Oncol. 2011;121:43-8.
PubMed Text format Related articles Abstract available

INCE U , Aydin O, Peker O
Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL
Gynecol Oncol. 2011;121:152-6.
PubMed Text format Related articles Abstract available

TSOUMPOU I , Valasoulis G, Founta C, Kyrgiou M, et al
High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
Gynecol Oncol. 2011;121:49-53.
PubMed Text format Related articles Abstract available

MOSS EL , Hirschowitz L, Luesley DM
Skin scar recurrence following removal of a sentinel lymph node containing a solitary micrometastasis of squamous cell vulval cancer.
Gynecol Oncol. 2011;121:239-40.
PubMed Text format Related articles

March 2011

MAXWELL GL , Hood BL, Day R, Chandran U, et al
Proteomic analysis of stage I endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VARUGHESE J , Cocco E, Bellone S, Bellone M, et al
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WONG TF , Takeda T, Li B, Tsuiji K, et al
Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BENN T , Brooks RA, Zhang Q, Powell MA, et al
Pelvic exenteration in gynecologic oncology: A single institution study over 20 years.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PATSAVAS K , Woessner J, Gielda B, Rotmensch J, et al
Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GEOMINI PM , Kruitwagen RF, Bremer GL, Massuger L, et al
Should we centralise care for the patient suspected of having ovarian malignancy?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PAULSEN T , Kaern J, Trope C
Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WRIGHT JD , Lewin SN, Barrena Medel NI, Sun X, et al
Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CORRENTI M , Medina F, Cavazza ME, Rennola A, et al
Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KWON JS , Mazgani M, Miller DM, Ehlen T, et al
The significance of surgical staging in intermediate-risk endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

THERIAULT C , Pinard M, Comamala M, Migneault M, et al
MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

JACOB F , Meier M, Caduff R, Goldstein D, et al
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

RAUH-HAIN JA , Growdon WB, Rodriguez N, Goodman AK, et al
Carcinosarcoma of the ovary: A case-control study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PETRY KU , Schmidt D, Scherbring S, Luyten A, et al
Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ROSE PG , Ali S, Whitney CW, Lanciano R, et al
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HARTER P , Muallem ZM, Buhrmann C, Lorenz D, et al
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MAGRINA JF , Pawlina W, Kho RM, Magtibay PM, et al
Robotic nerve-sparing radical hysterectomy: Feasibility and technique.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

USHA L , Sill MW, Darcy KM, Benbrook DM, et al
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LE T , Latifah H, Jolicoeur L, Weberpals J, et al
Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FAGOTTI A , Vizzielli G, Scambia G
RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers"
Gynecol Oncol. 2011.
PubMed Text format Related articles

OSANN K , Wenzel L, Dogan A, Hsieh S, et al
Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SIDERI M , Igidbashian S, Boveri S, Radice D, et al
Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALVAREZ RD
Gynecologic oncology group (GOG) report.
Gynecol Oncol. 2011.
PubMed Text format Related articles

YASMEEN A , Beauchamp MC, Piura E, Segal E, et al
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KETABI Z , Bartuma K, Bernstein I, Malander S, et al
Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

AL-WAHAB Z , Ali-Fehmi R, Cote ML, Elshaikh MA, et al
The impact of race on survival in uterine serous carcinoma: A hospital-based study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ERFANI N , Ghaderi A
ctla-4 gene variations in southern Iranian patients with cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SCHMELER KM , Frumovitz M, Ramirez PT
Conservative management of early stage cervical cancer: Is there a role for less radical surgery?
Gynecol Oncol. 2011;120:321-5.
PubMed Text format Related articles Abstract available

SOOD AK , Wilson MT, Herzog TJ
Supporting gynecologic cancer research: The last 20 years and beyond.
Gynecol Oncol. 2011;120:319-20.
PubMed Text format Related articles Abstract available

RAMIREZ P , Abu-Rustum NR
Novel diagnostic and therapeutic approaches in Gynecologic Oncology: Considerations for a new decade.
Gynecol Oncol. 2011;120:317-8.
PubMed Text format Related articles

Abstracts of the 42nd Annual Meeting of the Society of Gynecologic Oncologists. March 6-9, 2011, Orlando, Florida, USA.
Gynecol Oncol. 2011;120 Suppl 1:S1-149.
PubMed Text format Related articles

ZANVETTOR PH , Filho DF, Neves AR, Amorim MJ, et al
Laparoscopic surgical staging of locally advanced cervix cancer (IB2 to IVA): initial experience.
Gynecol Oncol. 2011;120:358-61.
PubMed Text format Related articles Abstract available

MCALPINE JN , El Hallani S, Lam SF, Kalloger SE, et al
Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.
Gynecol Oncol. 2011;120:385-92.
PubMed Text format Related articles Abstract available

TANYI JL , McCann G, Hagemann AR, Coukos G, et al
Clinical predictors of bevacizumab-associated gastrointestinal perforation.
Gynecol Oncol. 2011;120:464-9.
PubMed Text format Related articles Abstract available

CHU TY , Hsiung CA, Chen CA, Chou HH, et al
Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix.
Gynecol Oncol. 2011;120:449-53.
PubMed Text format Related articles Abstract available

EMBRY JR , Kelly MG, Post MD, Spillman MA, et al
Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
Gynecol Oncol. 2011;120:444-8.
PubMed Text format Related articles Abstract available

February 2011

FLEURY AC , Ibeanu OA, Bristow RE
Racial disparities in surgical care for uterine cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SHIH KK , Qin LX, Tanner EJ, Zhou Q, et al
A microRNA survival signature (MiSS) for advanced ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PARKINSON CA , Hatcher HM, Earl HM, Ajithkumar TV, et al
Multidisciplinary management of malignant ovarian germ cell tumours.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PHIPPEN NT , Lowery WJ, Banks NB, Leath CA 3rd, et al
Multiple synchronous primary ovarian malignancies in a patient with a MLH-1 mutation: Impact on potential fertility preservation.
Gynecol Oncol. 2011.
PubMed Text format Related articles

SERT MB , Abeler V
Robot-assisted laparoscopic radical hysterectomy: Comparison with total laparoscopic hysterectomy and abdominal radical hysterectomy; one surgeon's experience at the Norwegian Radium Hospital.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ALSBEIH G , Ahmed R, Al-Harbi N, Venturina LA, et al
Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARTINEZ A , Mery E, Querleu D
Response to micrometastases in para-aortic lymph nodes in advanced cervical cancer patients are a true predictor of recurrence at this level?
Gynecol Oncol. 2011.
PubMed Text format Related articles

KIM HS , Kim JH, Chung HH, Kim HJ, et al
Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CAPRI S , Gasparini R, Panatto D, Demarteau N, et al
Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KANG WD , Kim CH, Cho MK, Kim JW, et al
HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FARLEY J , Sill MW, Birrer M, Walker J, et al
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

YIN L , Grandi N, Raum E, Haug U, et al
Meta-analysis: Circulating vitamin D and ovarian cancer risk.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NUGENT EK , Hoff JT, Gao F, Massad LS, et al
Wound complications after gynecologic cancer surgery.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZHANG S , Royer R, Li S, McLaughlin JR, et al
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HOLMBERG LA , Goff B, Veljovich D
Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

REEVES KW , Carter GC, Rodabough RJ, Lane D, et al
Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CORRADO G , Salutari V, Fuoco G, Lucidi A, et al
Prolonged clinical response to trabectedin in a heavily pretreated patient with advanced uterine leiomyosarcoma: A case report and literature review.
Gynecol Oncol. 2011.
PubMed Text format Related articles

D'ANGELO E , Espinosa I, Ali R, Gilks CB, et al
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TODO Y , Kato H, Minobe S, Okamoto K, et al
Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

O'MALLEY DM , Richardson DL, Rheaume PS, Salani R, et al
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FARLEY J , Smith LM, Darcy KM, Brady MF, et al
Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: A gynecologic oncology group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FLEMING ND , Cass I, Walsh CS, Karlan BY, et al
CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

HYUN P , Seong SJ, Yoon BS
The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
Gynecol Oncol. 2011.
PubMed Text format Related articles

ATTIAS-GEVA Z , Bentov I, Fishman A, Werner H, et al
Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MARTINEZ A , Pomel C, Mery E, Querleu D, et al
Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

VAN LEEUWEN J , van der Putten HW, Demeyere TB, Creemers GJ, et al
Paraganglioma of the uterus A case report and review of literature.
Gynecol Oncol. 2011.
PubMed Text format Related articles

KATSAROS D , Gribaudo S
The proper use of multimodality treatment in locally advanced cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles

GIEN LT , Kupets R, Covens A
Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SCHILDKRAUT JM
Endometrial cancer.
Gynecol Oncol. 2011;120:165-6.
PubMed Text format Related articles

DOWNS LS JR , Chura JC, Argenta PA, Judson PL, et al
Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
Gynecol Oncol. 2011;120:265-9.
PubMed Text format Related articles Abstract available

EIJSINK JJ , Yang N, Lendvai A, Klip HG, et al
Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study.
Gynecol Oncol. 2011;120:280-3.
PubMed Text format Related articles Abstract available

ROSE PG , Brady MF
EORTC 55971: does it apply to all patients with advanced state ovarian cancer?
Gynecol Oncol. 2011;120:300-1.
PubMed Text format Related articles

AN HJ , Sung JM, Park AR, Song KJ, et al
Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression.
Gynecol Oncol. 2011;120:284-90.
PubMed Text format Related articles Abstract available

PRESS JZ , Allison KH, Garcia R, Everett EN, et al
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.
Gynecol Oncol. 2011;120:296-9.
PubMed Text format Related articles Abstract available

CRANE LM , Themelis G, Arts HJ, Buddingh KT, et al
Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.
Gynecol Oncol. 2011;120:291-5.
PubMed Text format Related articles Abstract available

January 2011

BRISTOW RE , Zahurak ML, Ibeanu OA
Racial disparities in ovarian cancer surgical care: A population-based analysis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PANICI PB , Di Donato V, Plotti F, Musella A, et al
Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

AUNE G , Lian AM, Tingulstad S, Torp SH, et al
Increased circulating hepatocyte growth factor (HGF): A marker of epithelial ovarian cancer and an indicator of poor prognosis.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SIOUTAS A , Schedvins K, Larson B, Gemzell-Danielsson K, et al
Three cases of vaginal radical trachelectomy during pregnancy.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MANDAL RK , Mittal RD
"Letter to editor" in lieu of article published below in Gynecol Oncolo. 2010 Oct;119(1):136-9 ctla-4 gene variations may influence cervical cancer susceptibility.
Gynecol Oncol. 2011.
PubMed Text format Related articles

MORGAN MA , Sill MW, Fujiwara K, Greer B, et al
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHEN J , Wang L, Matyunina LV, Hill CG, et al
Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CHENG X , Yang G, Schmeler KM, Coleman RL, et al
Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

MANGILI G , Sigismondi C, Lorusso D, Cormio G, et al
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

SONG YJ , Lim MC, Kang S, Seo SS, et al
Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ANGLESIO MS , Carey MS, Kobel M, Mackay H, et al
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DOS SANTOS LA , Garg K, Diaz JP, Soslow RA, et al
Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BELL-MCGUINN KM , Matthews CM, Ho SN, Barve M, et al
A phase II, single-arm study of the anti-alpha5beta1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

NO JH , Jeon YT, Park IA, Kim YB, et al
Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DEWDNEY SB , Benn T, Rimel BJ, Gao F, et al
Inferior vena cava filter placement in the gynecologic oncology patient: A 15-year institutional experience.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KINNEY W , Fetterman B, Cox JT, Lorey T, et al
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LACOUR RA , Westin SN, Meyer LA, Wingo SN, et al
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KOBAYASHI Y , Seino KI, Hosonuma S, Ohara T, et al
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GARG G , Shah JP, Toy EP, Field JB, et al
Intra-operative detection of nodal metastasis in early stage cervical cancer: A survey of the practice patterns of SGO members.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LACHANCE JA , Choudhri AF, Sarti M, Modesitt SC, et al
A nomogram for estimating the probability of ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

CRESS RD , Bauer K, O'Malley CD, Kahn AR, et al
Surgical staging of early stage epithelial ovarian cancer: Results from the CDC-NPCR ovarian patterns of care study.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

WEINBERG LE , Lurain JR, Singh DK, Schink JC, et al
Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

PLANTE M , Gregoire J, Renaud MC, Roy M, et al
The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ZEIMET AG , Fiegl H, Goebel G, Kopp F, et al
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LYBOL C , Thomas CM, Bulten J, van Dijck JA, et al
Increase in the incidence of gestational trophoblastic disease in The Netherlands.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

GELLER MA , Ivy JJ, Ghebre R, Downs LS Jr, et al
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TAPIA V , Gabler F, Munoz M, Yazigi R, et al
Tyrosine kinase A receptor (trkA): A potential marker in epithelial ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BAKHRU A , Buckanovich RJ, Griggs JJ
The impact of diabetes on survival in women with ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

KRUIJDENBERG CB , van den Einden LC, Hendriks JC, Zusterzeel PL, et al
Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

FINCH A , Metcalfe KA, Chiang JK, Elit L, et al
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

ESCOBAR PF , Kebria M, Falcone T
Evaluation of a novel single-port robotic platform in the cadaver model for the performance of various procedures in gynecologic oncology.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DIAZ JP , Gemignani ML, Pandit-Taskar N, Park KJ, et al
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

LEITAO MM JR , Barakat RR
Advances in the management of endometrial carcinoma.
Gynecol Oncol. 2011.
PubMed Text format Related articles

BURGER RA
Overview of anti-angiogenic agents in development for ovarian cancer.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

DIAZ-FEIJOO B , Perez-Benavente MA, Cabrera-Diaz S, Gil-Moreno A, et al
Change in clinical management of sentinel lymph node location in early stage cervical cancer The role of SPECT/CT.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BIJEN CB , Vermeulen KM, Mourits MJ, Arts HJ, et al
Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: A randomised trial.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

BEVIS KS , McNally LR, Sellers JC, Della Manna D, et al
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

TORNESELLO ML , Losito S, Benincasa G, Fulciniti F, et al
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
Gynecol Oncol. 2011.
PubMed Text format Related articles Abstract available

December 2010

BURGER EA , Kornor H, Klemp M, Lauvrak V, et al
HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

May 2010

STANLEY M
Pathology and epidemiology of HPV infection in females.
Gynecol Oncol. 2010;117.
PubMed Text format Related articles Abstract available

February 2010

CUZICK J
Long-term cervical cancer prevention strategies across the globe.
Gynecol Oncol. 2010.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: